Differential expression of metastasis-associated genes in primary tumor, circulating tumor cells, and metastasis of human giant-cell lung cancer cell line 95D
|更新时间:2026-01-09
|
Differential expression of metastasis-associated genes in primary tumor, circulating tumor cells, and metastasis of human giant-cell lung cancer cell line 95D
Journal of Army Medical UniversityVol. 33, Issue 10, Pages: 980-983(2011)
Li Xuetao,Chen Fanglin,Wang Xinxin,Sun Jianguo,Chen Zhengtang.Differential expression of metastasis-associated genes in primary tumor, circulating tumor cells, and metastasis of human giant-cell lung cancer cell line 95D[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(10):980-983.
Li Xuetao,Chen Fanglin,Wang Xinxin,Sun Jianguo,Chen Zhengtang.Differential expression of metastasis-associated genes in primary tumor, circulating tumor cells, and metastasis of human giant-cell lung cancer cell line 95D[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(10):980-983.DOI:
Differential expression of metastasis-associated genes in primary tumor, circulating tumor cells, and metastasis of human giant-cell lung cancer cell line 95D
Objective To analyze the differential expression of metastasis-associated genes (CD9
RHOA
MYL12A
B2M
PTOV1
and HSPA1B) in primary tumor
circulating tumor cells (CTCs)
and metastasis in a xenograft nude mouse model of lung cancer with spontaneous metastasis
which is established with highly metastatic human giant-cell lung cancer cell line 95D. Methods Metastasis-associated genes CD9
RHOA
MYL12A
B2M
PTOV1
and HSPA1B were selected according to previous experimental data and gene ontology analysis by GoSufer software. The xenograft nude mouse model of lung cancer was established with 95D cells steadily expressing green fluorescent protein (GFP). Fluorescence-activated cell sorting was used to purify the tumor cells in subcutaneous primary tumor
peripheral blood
and metastasis. Real-time PCR was used to detect relative expression levels of the above genes in the tumor cells. Results CD9
RHOA
and MYL12A had the lowest expression levels in CTCs
medium expression levels in liver metastasis
and the highest expression levels in primary tumor. PTOV1 had the highest expression level in CTCs
a medium expression level in subcutaneous primary tumor
and the lowest expression level in liver metastasis. B2M had the highest expression level in subcutaneous primary tumor
a medium expression level in CTCs
and the lowest expression level in liver metastasis. HSPA1B was detected only in subcutaneous primary tumor. Conclusion CD9
RHOA
MYL12A
B2M
and HSPA1B may be potential genes inhibiting lung cancer metastasis. Gene PTOV1 may contribute to the micrometastasis of lung cancer.